Cancer patients across the region are to benefit from a further £1.1million investment in new research by Yorkshire Cancer Research.
The investment includes six pioneering studies in Leeds and Sheffield that will trial a cancer treatment based around fish oil and support a research nurse based at Leeds St James’s Hospital among other things.
The announcement by Yorkshire Cancer Research is likely to be followed by further news that £5m of new funding will be unveiled in the next few weeks as the charity aims to prevent, diagnose and treat cancer more effectively in Yorkshire.
Dr Kathryn Scott, head of research funding for the charity, said: “We are extremely pleased to be able to announce another significant investment in patient focused research.
“The way to get new therapies and treatments into clinical practice is to fund research which tests the new treatments on patients directly so that we can ensure the findings made in the lab are translatable to humans.”
Thanks to the recent investment, the University of Leeds will use 843 colorectal cancer patient samples from a national clinical trial to analyse whether treatment with a combination of aspirin and fish oil can be of benefit to patients. Fish oil contains a natural compound called EPA that is thought to have anti-cancer properties.
The funding will also support a new research nurse at Leeds St James’s, who will recruit bladder cancer patients into clinical trails and collect samples for further studies.
Other projects to benefit include a three-year clinical trial involving 80 breast cancer patients at the University of Sheffield and a project focussing on the treatment of lung cancer, also run by the university.
Last year Yorkshire Cancer Research funded £4.3m of new projects.